APA (7th ed.) Citation

De Paz Linares, G. A., Opperman, R. M., Majumder, M., Lala, P. K., Hodivala-Dilke, K., & Munoz-Felix, J. M. (2021). Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis. Cancers, 13(5), 942. https://doi.org/10.3390/cancers13050942

Chicago Style (17th ed.) Citation

De Paz Linares, Guillermo Antonio, Reid Morgan Opperman, Mousumi Majumder, Peeyush K. Lala, Kairbaan Hodivala-Dilke, and Jose M. Munoz-Felix. "Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis." Cancers 13, no. 5 (2021): 942. https://doi.org/10.3390/cancers13050942.

MLA (9th ed.) Citation

De Paz Linares, Guillermo Antonio, et al. "Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis." Cancers, vol. 13, no. 5, 2021, p. 942, https://doi.org/10.3390/cancers13050942.